Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
218.11 +2.32 / +1.08%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
218.11 0.00 / 0.00%
 
Volume: 58.8K
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M+109.68%
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M+109.68%
Williams Glen
Senior Vice President-Technical Operations
Sale4/08/201539,863$96.08$3.8M+126.23%
Quinn Anthony
Sale4/06/201529,503$93.76$2.8M+135.06%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201426,960$90.06$2.4M+127.10%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale10/30/201422,904$80.11$1.8M+172.43%
Goldberg Mark Alan
Sale6/11/201421,597$80.00$1.7M+169.67%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201516,716$100.74$1.7M+120.60%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201514,750$99.97$1.5M+120.60%
Williams Glen
Senior Vice President-Technical Operations
Buy4/08/201524,600$57.56$1.4M+126.23%
Page of 10

To view my watchlist

Not a member yet?

Sign up now for a free account